Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?

Here's how Invesco's concentrated pharma play compares to Fidelity's diversified approach to healthcare stocks.

FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?

Published August 23, 2026 · Category: Finance

Overview

Both the Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) and the Invesco Pharmaceuticals ETF (NYSEMKT:PJP) focus on the medical space, but their underlying strategies, costs, and risk profiles differ significantly for long-term portfolios.

Understanding these structural differences is key to determining which fund best fits your needs. Here's how the two funds stack up on the most important factors for investors.

Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.